![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-desktop-headergif-63893.gif)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-mobile-headergif-78265.gif)
1. Imunovir
2. Inosiplex
3. Isoprinosin
4. Isoprinosine
5. Methisoprinol
6. Methysoprinol
7. Metisoprinol
8. Npt 10381
9. Npt-10381
10. Npt10381
11. Pranobex, Inosine
1. Isoprinosine
2. 36703-88-5
3. Inosiplex
4. Delimmun
5. Methisoprinol
6. Imunovir
7. Isoviral
8. Viruxan
9. Isoprinosin
10. Isoprinosina
11. Aviral
12. Inosine Acedobene Dimepranol
13. Imunoviral
14. Modimmunal
15. Immunovir
16. Pranosina
17. Pranosine
18. Np 113
19. Npt-10381
20. W1so0v223f
21. Np-113
22. Inosine Pranobex (jan)
23. Inosine-2-hydroxypropyldimethylammonium 4-acetamidobenzoate (1:3)
24. Inosine Pranobex [jan]
25. 4-acetamidobenzoic Acid,9-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3h-purin-6(9h)-one,1-(dimethylamino)propan-2-ol (3:1:3)
26. 4-acetamidobenzoic Acid;9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one;1-(dimethylamino)propan-2-ol
27. Inosine Pranobex [ban:jan]
28. Einecs 253-162-1
29. Ntp 10381
30. Unii-w1so0v223f
31. Groprinosin
32. Isoprinosine (tn)
33. Inosine, Compd. With 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (salt) (1:3)
34. Inosine, Compound With (2-hydroxypropyl)dimethylammonium P-acetamidobenzoate (1:3)
35. Inosine Pranobex [mi]
36. Chembl3833327
37. Inosine Pranobex [mart.]
38. Inosine Pranobex [who-dd]
39. Dtxsid401021342
40. Iad
41. Mfcd05662374
42. S5016
43. Akos025312516
44. Akos030228417
45. Ccg-270642
46. As-12319
47. Hy-107801
48. Cs-0030676
49. I1037
50. C74892
51. D01995
52. 703i885
53. A874300
54. Q3130053
55. P-acetamidobenzoic Salt Of N,n-dimethylamino-2-propanol & Inosine (3:1)
56. Inosine & 1-(dimethylamino)-2-propanol & 4-(acetylamino)benzoate (salt) (1:3:3)
57. 4-acetamidobenzoic Acid; 9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-purin-6-one; 1-(dimethylamino)propan-2-ol
58. 4-acetamidobenzoic Acid;9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-purin-6-one;1-(dimethylamino)propan-2-ol
Molecular Weight | 1115.2 g/mol |
---|---|
Molecular Formula | C52H78N10O17 |
Hydrogen Bond Donor Count | 13 |
Hydrogen Bond Acceptor Count | 22 |
Rotatable Bond Count | 14 |
Exact Mass | 1114.55464106 g/mol |
Monoisotopic Mass | 1114.55464106 g/mol |
Topological Polar Surface Area | 399 Ų |
Heavy Atom Count | 79 |
Formal Charge | 0 |
Complexity | 658 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 7 |
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
J - Antiinfectives for systemic use
J05 - Antivirals for systemic use
J05A - Direct acting antivirals
J05AX - Other antivirals
J05AX05 - Inosine pranobex